Adrenaline in the treatment of anaphylaxis: what is the evidence?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 14656845.
- Also identified by PMC identifier 286326.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Adrenaline (epinephrine) is the recommended first line treatment for patients with anaphylaxis. This review discusses the safety and efficacy of adrenaline in the treatment of anaphylaxis in the light of currently available evidence. A pragmatic approach to use of adrenaline auto-injectors is suggested.
Medical subject headings
- Anaphylaxis
- Epinephrine